Enabling people to become the pilots of their own high-functional longevity.

 

 

With the first minimum viable platform for the health care industry to place cardiovascular geroprotection* into the hands of everyone.

Our Approach

 

Target Cardiovascular Aging!

"Because man is only as old as his arteries." 

Thomas Sydenham, English physician, 1624-1689

 

Treating cardiovascular aging simultaneously prevents multiple aging-related diseases.

Uncover Biomarkers of Aging.

Aging and disease are defined as the gradual loss of function.

We therefore developed the first in-silico model of the CV system to

uncover its modifiable biomarkers of function and aging -

the CV functionome.

Create A Mimimum Viable Platform.

To help the health care industry test the benefits of geroprotection now.

  • Reducing the CVD burden (for health care payers)

  • Accelerating research (for pharma & biotech)

  • Defusing the demographic aging transition 

 

Our Project Team

 
Lutz E. Kraushaar, Dr.PH
  • Grey LinkedIn Icon
  • Grey Xing
  • RGlogo

Project Founder,

Cardiovascular Function Diagnostics and Public Health

Alexander Dressel, Dr. rer.nat.
  • Grey LinkedIn Icon
  • RGlogo

Founding Partner

Mathematical Modeling & Statistics

Pascal Bauer, Dr. med.
  • Grey LinkedIn Icon
  • RGlogo

Founding Partner

Head of Depts. Angiology, Sports Cardiology & CV Prevention

University Hospital Giessen, Germany 

Moritz Gmelin, Dipl. Ing.
  • Grey Xing

IT Infrastructure,

Managing Director avetana GmbH, Karlsruhe, Germany.

Wen An Yong, Prof. Dr.
  • Grey LinkedIn Icon
  • RGlogo

Mathematical Modeling, 

Director Zhou Pei-Yuan Center for Applied Mathematics, Beijing, China.

Klaus Reichenbach, Dipl. Ing.

Medical Technology Engineering,

Managing Director livetec Ingenieurbüro GmbH, Lörrach, Germany.

    Work    

Mario Botsch, Prof. Dr.
  • Grey LinkedIn Icon

Interactive Virtual Reality & Avatars

Computer Science Dept., Bielefeld University, Bielefeld, Germany.

Sabrina Hegner, Prof. Dr. 
  • Grey LinkedIn Icon
  • Grey Xing
  • RGlogo

Consumer Psychology,

Dept. Business & Health, University of Applied Sciences, Bielefeld, Germany.

Ardion Beldad, Asst. Prof. Dr.
  • Grey LinkedIn Icon
  • RGlogo

Data Privacy & Human-IT Interaction

Faculty of Behavioral, Management, and Social Sciences, University of Twente, The Netherlands

Fabian Stichnoth, Dr. rer. pol.
  • Grey LinkedIn Icon
  • Grey Xing

Health Sector Project Implementation,

Managing Director, smart insights GmbH, Bremen, Germany

Jon Brassey
  • Grey LinkedIn Icon

Clinical Search Engine Development,

Director TRIP Database,

Honorary Fellow at CEBM,

University of Oxford, UK.

Our Funding Partners

 

The Development Pipeline

 

Key Publications

The following contains links to research from our team (in bold) and others, using websites owned and operated by third parties.

A novel principled method for the measurement of vascular robustness uncovers hidden risk for premature CVD death.

L. Kraushaar, A. Dressel

Journal of Applied Physiology, 2018

The cardiovascular robustness hypothesis: Unmasking young adults’ hidden risk for premature cardiovascular death

L. Kraushaar, A. Dressel

Medical Hypotheses 2018

Strategies for Optimal Cardiovascular Aging

DR Seals et al. 

Heart & Circulatory Physiology 2018

Substantial health and economic returns from delayed aging may warrant a new focus for medical research

Goldman, D. et al. 

Health Affairs 2013

 
 

    Contact